Background/aim: The aim of this paper was to determine the general tendencies of urology patients and effect of COVID-19 pandemic on daily urological practice at tertiary centers located in the most affected area in Turkey. Materials and methods: We retrospectively analyzed the data of 39,677 patients (group 1) that applied to 6 different large-volume tertiary centers in Istanbul for outpatient consultation, surgery, or other procedures in the 3-month period between March 16 and June 14, 2020. The distribution of the number of patients who applied to subspecialty sections of urology outpatient clinics and inpatient services were recorded by weeks. That data was compared to data obtained from 145,247 patients that applied to the same centers in the same period of the previous year (group 2). The reflection of worldwide and Turkish COVID-19 case distribution on the daily urological practice was analyzed. Results: There was a decrease in the number of patients in all subspecialty sections the in group 1 compared to group 2; however, there was a significant proportional increase in urooncology and general urology admissions. A decrease of approximately 75% was observed in the total number of surgeries (p < 0.001). We detected a negative correlation between the numbers of admission to all outpatient clinics and COVID-19 cases or deaths in Turkey (p < 0.05). The same negative correlation was present for all surgical procedures and consultations (p < 0.05). The multivariate linear regression analysis revealed that the number of cases in Turkey, and the number of deaths worldwide affect the number of outpatient clinic admissions (R-2 = 0.38, p = 0.028) and urological surgery (R-2 = 0.33, p = 0.020) in Turkey negatively. Conclusion: This novel pandemic has implications even for urology practice. Urological surgical procedures were more affected by COVID-19-related deaths in Turkey and worldwide. Outpatient admissions and urological surgeries decreased significantly by increasing COVID-19 case numbers in Turkey and worldwide deaths.
Purpose: Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) have emerged as important regulators of the epithelial–mesenchymal transition (EMT) and tumor progression. The present study evaluated the expression profiles of lncRNA ZEB1-AS1 and miR-200b-3p in non-muscle-invasive bladder cancer (NMIBC) tissues and investigated their associations with clinicopathological characteristics. Materials and Methods: Tumor tissues and matched adjacent normal bladder tissue were obtained from 50 patients with primary NMIBC who underwent transurethral resection of bladder tumors. Total RNA was extracted, and expression levels of ZEB1-AS1 and miR-200b-3p were measured using quantitative real-time polymerase chain reaction (qRT-PCR). Relative expression levels were calculated using the 2−ΔΔCT method. Associations between gene expression levels and clinicopathological parameters were analyzed using non-parametric statistical tests. Receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic performance. Results: ZEB1-AS1 and miR-200b-3p demonstrated significantly increased expression in tumor tissues compared with adjacent normal bladder tissue (p = 0.018 and p = 0.034, respectively). ZEB1-AS1 expression was significantly higher in high-grade tumors (p = 0.007), whereas miR-200b-3p expression was more pronounced in low-grade tumors (p = 0.015). No significant associations were identified between expression levels and tumor stage, carcinoma in situ, or variant histology. ROC analysis demonstrated modest diagnostic performance, with AUC values of 0.637 for ZEB1-AS1 and 0.624 for miR-200b-3p. Conclusions: ZEB1-AS1 and miR-200b-3p demonstrated distinct expression patterns associated with tumor grade and may contribute to EMT-associated molecular heterogeneity in NMIBC. Although the individual diagnostic performance of these markers appeared limited, the present findings provide additional insight into non-coding RNA-associated pathways and support further investigation in larger validation studies.